Due in part to increasing rates of obesity, another major risk factor is emerging, metabolic dysfunction-associated steatotic ...

HCC risk prediction may be poorly reported and biased for individuals with nonviral chronic liver disease.

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

Altimmune’s lead drug Pemvidutide demonstrates significant progress in obesity and liver health. See why ALT stock is a ...

Discover a new study that has examined the influence of clinical and histologic risk factors on long-term MASLD outcomes in ...

MASLD diagnosis was associated with an increased risk for youth-onset type 2 diabetes among pediatric patients with obesity.

Eating high-fat dairy products which include whole milk, cream, frozen yoghurt, butter, and ghee, may increase the risk of ...

This review discussed experimental mouse models used in the pre-clinical study of liver fibrosis regression, a pivotal ...

The success surrounding the medications for obesity and diabetes has sparked research into whether they could also be an ...

Children with obesity and metabolic dysfunction–associated steatotic liver disease (MASLD) have a higher risk for youth-onset type 2 diabetes (T2D), and the risk increases dramatically in the ...

Liver diseases are any diseases that affect the functioning of the liver. Liver diseases can be inherited (such as Wilson disease and alpha 1-antitrypsin deficiency) or acquired (for example ...

Hepatology is a medical specialty focusing on the structure, function, pathology and disorders of the liver, gall bladder and bile ducts. The year 2024 was momentous for metabolic dysfunction ...